CPHI Shanghai 2019

Five years Shanghai exhibition experience, with more than ten years of painstaking efforts!
Chengdu Pukang biotechnology co., ltd. participated in the 19th world Chemical Pharmaceutical Ingredient exhibition China（CPHI  China） held in the new international expo center in Shanghai from June 18 to June 20, 2019. It was also the second time that pukang met with many customers since the American exhibition in May. At present, our company is committed to the synthesis of non-natural amino acids, focusing on the production of small molecule PEG, and we have build a long-t½ drugs development platform together with many peptide enterprises. our product series include intermediates of Albuvirtide, semaglutide, liraglutide and insulin degludec etc.. Pukang has long been committed to the research and development of long-term drug side chain, to reduce the cost of medication for patients and improve patient compliance as well as to contribute to human health and happiness.
On the first day of the exhibition, our booth welcomed an constant stream of visitors and exhibitors. During the conversation, we exchanged different ideas and views with each other. And our colleagues also recommended our products and introduced our selling points and advantages. The atmosphere there was bustling.

In 2019 Shanghai CPHI exhibition, Pukang has gained many new partners, and also received the demands of different customers from all over the world. The high demands of customers are our goal to strive forward. Our purpose is dedicated to customer service, and driven by customer demands!" With ten years of efforts, Pukang has established a mature R&D team and sales model. We hope that in the long term development in the future, we can continue to give full play to our advantages and build a long-term drug R&D platform together with new drug discovery enterprises.